ArticlebioRxiv : the preprint server for biology2025
Reconstructing EBV reactivation and DNA damage response kinetics in morphologic pseudotime.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
3 authors.
Funding
Abstract
Epstein-Barr virus (EBV) lytic infection contributes to virus-associated cancers and autoimmunity and depends on viral subversion of host DNA damage responses (DDR). Here, we use high-content screening (HCS) for morphologic and pseudotemporal profiling of single-cell EBV reactivation and DDR dynamics spanning seven lytic induction treatments in nine B cell lymphoma models. We generated an atlas (>750,000 cells) of spatiotemporally distinct phenotypes of immediate-early (IE) and late lytic proteins, viral and cellular DNA replication, and double-stranded break (DSB) DDR factors. Single-cell segmentation, feature extraction, and clustering identify treatment- and model-dependent cell responses and lytic induction. Notably, genotoxin-induced DDR profiles differ in lytic versus latent cells, and lytic protein localization varies across pharmacologic and physiologic stimuli. Pseudotime trajectories of physiologic reactivation reveal viral replication compartment (VRC) nucleation and expansion alongside concomitant host DDR localization. The early DDR marker γH2AX is depleted from VRCs but widespread across host chromatin throughout reactivation. Surprisingly, the lytic-essential late DDR protein 53BP1 is present in lytic cells prior to viral genome replication but subsequently absent from VRCs and host chromatin, indicating spatial and kinetic DDR dysregulation during EBV reactivation. Collectively, these data support a model wherein EBV transiently employs host DSB DDR mediators to initiate genome replication while a host-targeted DDR is initiated but impaired. We further demonstrate biological generalizability and utility of the method across confocal and epifluorescence systems. Thus, this work demonstrates a powerful technique to recover host-virus dynamics from static timepoints and will support future high-throughput single-cell virology applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.